20 results
PRE 14A
ATHA
Athira Pharma, Inc.
28 Mar 24
Preliminary proxy
8:47am
in Control and Severance Agreements
Equity Incentive Plans
Clawback Policy
Executive Incentive Compensation Plan
SECURITY OWNERSHIP OF CERTAIN … ;
reviews and discusses our compensation policies and practices and the risks related thereto;
approves the creation or revision of any clawback policy
8-K
EX-10.1
ATHA
Athira Pharma, Inc.
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
or performance conditions of an Award. Notwithstanding any provisions to the contrary under this Plan, an Award shall be subject to the Company’s clawback … Street Reform and Consumer Protection Act) (the “Clawback Policy”). The Administrator may require a Participant to forfeit, return or reimburse
8-K
EX-10.1
ATHA
Athira Pharma, Inc.
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.
8.Clawback … under any law, government regulation or stock exchange listing requirement, will be subject to such deductions and clawback as may be required to be made
DEFC14A
zalo46 aan0a1
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
u0feu
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
DEF 14A
j8n69a
16 Apr 21
Definitive proxy
6:02am
10-K
c7z jcoq677uy8zc
25 Mar 21
Annual report
12:00am
424B4
8vnzwbnw yi9sy
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
mradlg xa8
6 Jan 21
Draft registration statement
12:00am
424B4
ejm95rf
18 Sep 20
Prospectus supplement with pricing info
4:05pm
S-1
sp1y8jx9xrv
26 Aug 20
IPO registration
5:25pm
DRS
a89ku x2zfxvei0
24 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next